Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Peritoneal dialysis (PD)-associated peritonitis is a serious complication that causes deterioration of peritoneal function and residual renal function. Therefore, we urge patients to comprehend the notion of sanitation to avert peritonitis and repeatedly educate them on the technique of bag exchange. Despite such efforts, for patients who develop peritonitis, we provide renewed guidance tailored to the causative bacteria. This is because peritonitis that recurs within a relatively short period not only causes this functional impairment but also risks discontinuation of peritoneal dialysis. Consequently, it is imperative to identify high-risk patients during their initial episode of peritonitis and implement comprehensive preventive measures to avert a subsequent recurrence.
In this study, we explore factors associated with patients who experience early second episode of PD-related peritonitis.
We retrospectively collected medical records of PD patients at our hospital who developed initial peritonitis between 2005 and 2023. The analysis excluded cases of peritonitis that required surgical intervention, such as appendicitis, intestinal perforation, Mycobacterium or Fungal/yeast peritonitis, and recurrent peritonitis. Clinical data Age, gender, PD history, presence of diabetes, medication (steroids, acid suppressants), type of causative pathogen, serum albumin, potassium, CRP, initial and peak drainage WBC etc. are collected. The Data were compared between patients who developed a second episode of peritonitis within 30 months (Early group) and those who did not (control group). Additionally, factors associated with the interval between the initial and second episodes of peritonitis were examined within the Early group.
Of the 83 patients who developed initial peritonitis during the observation period, 65 were included in the analysis, and 18 were excluded based on the exclusion criteria. Among these 65 patients, 22 who had a second peritonitis within 30 months were in the Early group and 43 were in the Control group. Between the two groups, there were no significant differences in gender, PD vintage, presence of diabetes, type of causative pathogen, serum albumin, potassium, CRP, initial and peak drainage WBC. However, the Early group had significantly higher age (median age 70 vs 57, p=0.002, SMD 0.947) and shorter time from peritonitis onset to hospital arrival (3hours vs 9 hours, p=0.009, SMD 0.514) compared to the control group. In the early group, the time to second-episode peritonitis was significantly shorter in patients who experienced abdominal pain and in those who had taken acid suppressants.
Patients who are older at the time of their initial PD-related peritonitis infection and who experience a shorter interval between symptom onset and medical consultation may be at risk for developing a second episode of peritonitis at an earlier stage.
